Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anne Marie Werlinrud"'
Autor:
Martine G Aabye, Jesper Eugen-Olsen, Anne Marie Werlinrud, Line Lindebo Holm, Tamara Tuuminen, Pernille Ravn, Morten Ruhwald
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e39228 (2012)
BACKGROUND: Antigen specific release of IP-10 is an established marker for infection with M.tuberculosis. Compared to IFN-γ, IP-10 is released in 100-fold higher concentrations enabling the development of novel assays for detection. Dried blood spot
Externí odkaz:
https://doaj.org/article/b28afc063d4e427bb6044cd939e9b817
Autor:
Frank A, Post, Daniel, Grint, Anne Marie, Werlinrud, Alexander, Panteleev, Vieja, Riekstina, Evgeniy A, Malashenkov, Alena, Skrahina, Dan, Duiculescu, Daria, Podlekareva, Igor, Karpov, Vasiliy, Bondarenko, Nelly, Chentsova, Jens, Lundgren, Amanda, Mocroft, Ole, Kirk, Jose M, Miro, N, Chentsova
Publikováno v:
Journal of Infection. 68:259-263
Observational data from Eastern Europe on the management and outcome of multi-drug-resistant tuberculosis (MDR TB) in HIV positive populations remain sparse in the English-language literature. We compared clinical characteristics and outcomes of 55 p
Autor:
Morten Ruhwald, Anne Marie Werlinrud, Jesper Eugen-Olsen, Martine G. Aabye, Line Lindebo Holm, Tamara Tuuminen, Pernille Ravn
Publikováno v:
PLoS ONE, Vol 7, Iss 6, p e39228 (2012)
PLoS ONE
PLoS ONE
Background Antigen specific release of IP-10 is an established marker for infection with M.tuberculosis. Compared to IFN-γ, IP-10 is released in 100-fold higher concentrations enabling the development of novel assays for detection. Dried blood spots
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a266c915e44892f0b233121b5b8a21ff
http://hdl.handle.net/10138/165775
http://hdl.handle.net/10138/165775
Autor:
Bolette Søborg, Anne Marie Werlinrud, Pernille Ravn, Erika Belard, Inge Nordgaard-Lassen, Synne Semb, Annette Brylov, Henrik S. Thomsen, Morten Ruhwald, Merete Lund Hetland, Frank Krieger Jensen
Publikováno v:
Inflammatory bowel diseases. 17(11)
Background: During screening for latent tuberculosis infection (LTBI), before anti-tumor-necrosis-factor-α treatment, most patients are already receiving immunosuppressive therapy. The objective was to evaluate the performance of the QuantiFERON Gol
Autor:
Inge Nordgaard-Lasen, Merete Lund Hetland, Anne Marie Werlinrud, Pernille Ravn, Erika Belard, Morten Ruhwald, Synne Semb, Frank Krieger Jensen, Bolette Soeborg
Publikováno v:
Gastroenterology. 138:S-523
Introduction: Detection of Latent Tuberculosis Infections (LTBI) in patients with autoimmune diseases (e.g. Inflammatory Bowel Disease, Rheumatological Diseases) prior to treatment with anti-TNFα is mandatory because of the risk of reactivation of L
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.